Antibodies immunoreactive with heregulin-coupled HER3

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9321839
APP PUB NO 20140370548A1
SERIAL NO

14475348

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Recombinant materials and methods for producing antibodies that specifically bind heregulin-coupled HER3, at a site distinct from the heregulin binding site, are described. These antibodies are particularly useful in treating cancer that expresses HER3.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRELLIS BIOSCIENCE LLC702 MARSHALL ST SUITE 614 REDWOOD CITY CA 94063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Collarini, Ellen J Oakland, US 10 134
Fatholahi, Marjan Mountain View, US 3 38
Foord, Orit Foster City, US 95 1360
Kauvar, Lawrence M San Francisco, US 100 1197
Keyt, Bruce Hillsborough, US 44 686
Nguyen, Hung American Canyon, US 183 7565
Sperinde, Gizette El Granada, US 10 76

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 26, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00